Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

A Hidden Markov Model for 3D Catheter Tip Tracking With 2D X-ray Catheterization Sequence and 3D Rotational Angiography.

Ambrosini P, Smal I, Ruijters D, Niessen WJ, Moelker A, Van Walsum T.

IEEE Trans Med Imaging. 2017 Mar;36(3):757-768. doi: 10.1109/TMI.2016.2625811. Epub 2016 Nov 7.

PMID:
27845655
2.

Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.

Oluwabusi OO, Parke S, Ambrosini PJ.

World J Clin Pediatr. 2016 Feb 8;5(1):128-35. doi: 10.5409/wjcp.v5.i1.128. eCollection 2016 Feb 8.

3.

Continuous roadmapping in liver TACE procedures using 2D-3D catheter-based registration.

Ambrosini P, Ruijters D, Niessen WJ, Moelker A, van Walsum T.

Int J Comput Assist Radiol Surg. 2015 Sep;10(9):1357-70. doi: 10.1007/s11548-015-1218-x. Epub 2015 May 20.

4.

IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.

Ambrosini P, Loiacono F, Conte R, Moretta L, Vitale C, Mingari MC.

Eur J Immunol. 2015 Jul;45(7):2061-71. doi: 10.1002/eji.201445326. Epub 2015 May 12. Erratum in: Eur J Immunol. 2015 Aug;45(8):2420.

5.

IL-1β-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors.

Vitale C, Ambrosini P, Montaldo E, Ballerini F, Moretta L, Mingari MC.

Haematologica. 2015 Feb;100(2):e42-5. doi: 10.3324/haematol.2014.110494. Epub 2014 Oct 24. No abstract available.

6.

Relative contribution of haptic technology to assessment and training in implantology.

Joseph D, Jehl JP, Maureira P, Perrenot C, Miller N, Bravetti P, Ambrosini P, Tran N.

Biomed Res Int. 2014;2014:413951. doi: 10.1155/2014/413951. Epub 2014 Feb 20.

7.

Synthetic cannabinoid-induced psychosis: two adolescent cases.

Oluwabusi OO, Lobach L, Akhtar U, Youngman B, Ambrosini PJ.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):393-5. doi: 10.1089/cap.2012.0004. No abstract available.

PMID:
23083027
8.

Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood.

Ambrosini PJ, Bennett DS, Elia J.

J Affect Disord. 2013 Feb 15;145(1):70-6. doi: 10.1016/j.jad.2012.07.014. Epub 2012 Aug 4.

9.

Using a plant hormone and a thioligand to improve phytoremediation of Hg-contaminated soil from a petrochemical plant.

Cassina L, Tassi E, Pedron F, Petruzzelli G, Ambrosini P, Barbafieri M.

J Hazard Mater. 2012 Sep 15;231-232:36-42. doi: 10.1016/j.jhazmat.2012.06.031. Epub 2012 Jun 23.

PMID:
22771350
10.

Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

Montaldo E, Vitale C, Cottalasso F, Conte R, Glatzer T, Ambrosini P, Moretta L, Mingari MC.

Blood. 2012 Apr 26;119(17):3987-96. doi: 10.1182/blood-2011-09-379693. Epub 2012 Mar 7.

11.

What can ADHD without comorbidity teach us about comorbidity?

Takeda T, Ambrosini PJ, deBerardinis R, Elia J.

Res Dev Disabil. 2012 Mar-Apr;33(2):419-25. doi: 10.1016/j.ridd.2011.09.024. Epub 2011 Nov 24.

PMID:
22119689
12.

Parental ADHD status and its association with proband ADHD subtype and severity.

Takeda T, Stotesbery K, Power T, Ambrosini PJ, Berrettini W, Hakonarson H, Elia J.

J Pediatr. 2010 Dec;157(6):995-1000.e1. doi: 10.1016/j.jpeds.2010.05.053. Epub 2010 Jul 14.

PMID:
20630538
13.

ADHD latent class clusters: DSM-IV subtypes and comorbidity.

Elia J, Arcos-Burgos M, Bolton KL, Ambrosini PJ, Berrettini W, Muenke M.

Psychiatry Res. 2009 Dec 30;170(2-3):192-8. doi: 10.1016/j.psychres.2008.10.008. Epub 2009 Nov 8.

14.

Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorder.

Elia J, Takeda T, Deberardinis R, Burke J, Accardo J, Ambrosini PJ, Blum NJ, Brown LW, Lantieri F, Berrettini W, Devoto M, Hakonarson H.

J Pediatr. 2009 Aug;155(2):239-44.e5. doi: 10.1016/j.jpeds.2009.02.031. Epub 2009 May 15.

PMID:
19446845
15.

Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.

Elia J, Capasso M, Zaheer Z, Lantieri F, Ambrosini P, Berrettini W, Devoto M, Hakonarson H.

Psychiatr Genet. 2009 Jun;19(3):134-41. doi: 10.1097/YPG.0b013e32832a5043.

PMID:
19352218
16.

ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents.

Elia J, Ambrosini P, Berrettini W.

Child Adolesc Psychiatry Ment Health. 2008 Jul 3;2(1):15. doi: 10.1186/1753-2000-2-15.

17.

Sertraline in children and adolescents with major depressive disorder.

Donnelly CL, Wagner KD, Rynn M, Ambrosini P, Landau P, Yang R, Wohlberg CJ.

J Am Acad Child Adolesc Psychiatry. 2006 Oct;45(10):1162-70.

PMID:
17003661
18.
19.

Long-term sertraline treatment of children and adolescents with major depressive disorder.

Rynn M, Wagner KD, Donnelly C, Ambrosini P, Wohlberg CJ, Landau P, Yang R.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):103-16.

PMID:
16553532
20.

A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.

Ambrosini PJ, Sallee FR, Lopez FA, Shi L, Michaels MA; LADD.CAT Study Group.

Curr Med Res Opin. 2006 Feb;22(2):427-40.

PMID:
16466615
21.

Gender differences in adolescent depression: do symptoms differ for boys and girls?

Bennett DS, Ambrosini PJ, Kudes D, Metz C, Rabinovich H.

J Affect Disord. 2005 Dec;89(1-3):35-44. Epub 2005 Oct 10.

PMID:
16219362
22.
23.

Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger.

Lekhwani M, Nair C, Nikhinson I, Ambrosini PJ.

J Child Adolesc Psychopharmacol. 2004 Spring;14(1):95-103.

PMID:
15142396
24.

Analysis of etiologic factors and periodontal conditions involved with 309 abfractions.

Miller N, Penaud J, Ambrosini P, Bisson-Boutelliez C, Briançon S.

J Clin Periodontol. 2003 Sep;30(9):828-32.

PMID:
12956659
25.

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.

Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D; Sertraline Pediatric Depression Study Group.

JAMA. 2003 Aug 27;290(8):1033-41.

PMID:
12941675
26.

49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA.

Ambrosini PJ, Elia J, Rynn MA.

Expert Opin Pharmacother. 2003 Apr;4(4):591-4.

PMID:
12667122
27.

Taxonicity of adolescent melancholia: a categorical or dimensional construct?

Ambrosini PJ, Bennett DS, Cleland CM, Haslam N.

J Psychiatr Res. 2002 Jul-Aug;36(4):247-56.

PMID:
12191629
28.

A laser Doppler study of gingival blood flow variations following periosteal stimulation.

Ambrosini P, Cherene S, Miller N, Weissenbach M, Penaud J.

J Clin Periodontol. 2002 Feb;29(2):103-7.

PMID:
11895537
29.

Childhood depression: pharmacological therapy/treatment (pharmacotherapy of childhood depression).

Wagner KD, Ambrosini PJ.

J Clin Child Psychol. 2001 Mar;30(1):88-97. Review.

PMID:
11294082
30.

A review of pharmacotherapy of major depression in children and adolescents.

Ambrosini PJ.

Psychiatr Serv. 2000 May;51(5):627-33. Review.

PMID:
10783181
31.
32.

Does guanfacine cause hallucinations in children?

Luthra V, Markov D, Ambrosini P.

J Child Adolesc Psychopharmacol. 1999;9(4):313-4. No abstract available.

PMID:
10630462
33.

Regeneration of bone graft donor sites.

Miller NA, Penaud J, Kohler C, Ambrosini P.

Clin Oral Implants Res. 1999 Aug;10(4):326-30.

PMID:
10551075
34.

Prolactin secretion in depressed children.

Hardan A, Birmaher B, Williamson DE, Dahl RE, Ambrosini P, Rabinovich H, Ryan ND.

Biol Psychiatry. 1999 Aug 15;46(4):506-11.

PMID:
10459400
35.

Multicenter open-label sertraline study in adolescent outpatients with major depression.

Ambrosini PJ, Wagner KD, Biederman J, Glick I, Tan C, Elia J, Hebeler JR, Rabinovich H, Lock J, Geller D.

J Am Acad Child Adolesc Psychiatry. 1999 May;38(5):566-72.

PMID:
10230188
36.

Treatment of attention-deficit-hyperactivity disorder.

Elia J, Ambrosini PJ, Rapoport JL.

N Engl J Med. 1999 Mar 11;340(10):780-8. Review. No abstract available.

PMID:
10072414
37.

Increased plasma valproate concentrations when coadministered with guanfacine.

Ambrosini PJ, Sheikh RM.

J Child Adolesc Psychopharmacol. 1998;8(2):143-7.

PMID:
9730080
38.

Relationship of Beck Depression Inventory factors to depression among adolescents.

Bennett DS, Ambrosini PJ, Bianchi M, Barnett D, Metz C, Rabinovich H.

J Affect Disord. 1997 Sep;45(3):127-34.

PMID:
9298425
39.

Pancreatitis associated with serotonin-dopamine antagonists.

Nishawala MA, Callaghan M, Malatack JJ, Moughan B, Ambrosini PJ, Price B, Elia J.

J Child Adolesc Psychopharmacol. 1997;7(3):211-3. No abstract available.

PMID:
9466237
40.

Resorption rates of 2 commercially available bioresorbable membranes. A histomorphometric study in a rabbit model.

Miller N, Penaud J, Foliguet B, Membre H, Ambrosini P, Plombas M.

J Clin Periodontol. 1996 Dec;23(12):1051-9.

PMID:
8997647
41.

The 24-hour pattern of prolactin secretion in depressed and normal adolescents.

Waterman GS, Dahl RE, Birmaher B, Ambrosini P, Rabinovich H, Williamson D, Novacenko H, Nelson B, Puig-Antich J, Ryan ND.

Biol Psychiatry. 1994 Apr 1;35(7):440-5.

PMID:
8018794
42.

Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders.

Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J.

J Am Acad Child Adolesc Psychiatry. 1993 May;32(3):483-93. Review.

PMID:
8496110
43.

The psychosocial functioning and family environment of depressed adolescents.

Puig-Antich J, Kaufman J, Ryan ND, Williamson DE, Dahl RE, Lukens E, Todak G, Ambrosini P, Rabinovich H, Nelson B.

J Am Acad Child Adolesc Psychiatry. 1993 Mar;32(2):244-53.

PMID:
8444751
44.

Antidepressant treatments in children and adolescents. I. Affective disorders.

Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J.

J Am Acad Child Adolesc Psychiatry. 1993 Jan;32(1):1-6. Review.

PMID:
8428861
45.

The dexamethasone suppression test in adolescent outpatients with major depressive disorder.

Birmaher B, Dahl RE, Ryan ND, Rabinovich H, Ambrosini P, al-Shabbout M, Novacenko H, Nelson B, Puig-Antich J.

Am J Psychiatry. 1992 Aug;149(8):1040-5.

PMID:
1636803
46.

Regulation of sleep and growth hormone in adolescent depression.

Dahl RE, Ryan ND, Williamson DE, Ambrosini PJ, Rabinovich H, Novacenko H, Nelson B, Puig-Antich J.

J Am Acad Child Adolesc Psychiatry. 1992 Jul;31(4):615-21. Review.

PMID:
1644723
47.

Dexamethasone suppression test in children with major depressive disorder.

Birmaher B, Ryan ND, Dahl R, Rabinovich H, Ambrosini P, Williamson DE, Novacenko H, Nelson B, Lo ES, Puig-Antich J.

J Am Acad Child Adolesc Psychiatry. 1992 Mar;31(2):291-7. Erratum in: J Am Acad Child Adolesc Psychiatry 1992 May;31(3):561.

PMID:
1564032
48.

Platelet imipramine binding in depressed children and adolescents.

Ambrosini PJ, Metz C, Arora RC, Lee JC, Kregel L, Meltzer HY.

J Am Acad Child Adolesc Psychiatry. 1992 Mar;31(2):298-305.

PMID:
1314256
49.

Hormonal responses to dextroamphetamine in depressed and normal adolescents.

Waterman GS, Ryan ND, Puig-Antich J, Meyer V, Ambrosini PJ, Rabinovich H, Stull S, Novacenko H, Williamson DE, Nelson B.

J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):415-22.

PMID:
2055877
50.

Thyroid stimulating hormone response to thyrotropin in prepubertal depression.

Garcia MR, Ryan ND, Rabinovitch H, Ambrosini P, Twomey J, Iyengar S, Novacenko H, Nelson B, Puig-Antich J.

J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):398-406.

PMID:
1905294

Supplemental Content

Loading ...
Support Center